Indian scientists closer to a new treatment for blood cancer
The new drug can kill over 70 per cent blood cancer cells in a petri dish in 48 hours at an extremely low concentration
For future cancer drugs, scientists find clues from outer space
They are exploring if the knowledge of microgravity can be used to develop novel ways to find new drugs
Drug cures rectal cancer patients in new trial. Will this impact current course of treatment?
Patients part of the study didn't require any chemotherapy or surgery
Now, chickens lay eggs with anti-cancer drugs
These chickens were genetically modified by Scottish researchers, who say that this method is 100 times cheaper than producing the drugs in factories
New method for controlled release makes cancer drugs less toxic to healthy tissues
This is a hydrogel-based treatment method releases drugs slowly increasing its efficiency
Cancer's other face
In what reads like a mystery novel, Christofferson proposes the theory of deranged metabolism and not genetic mutation as the likely cause of cancer
Fight for biosimilars
Roche’s injunction against Biocon’s breast cancer drug signals the tough road ahead
Younger people are more prone to cancer, here is why
Risk factors include — highly processed foods, sugary beverages, weight, type 2 diabetes, sedentary lifestyle, sleep deprivation and …
World’s first ‘Darwinian’ cancer drug plan could be a game changer
The programme based on artificial intelligence that will help forecast cancers and treat them better could be of immense benefit to patients …
Look back at the decade: Generic drugs
Fifteen years after it rose and went limp, the biotech sector saw a bull run of sorts
Cancer growth in the body could originate from a single cell – target it to revolutionise treatment
Researchers identify and isolate cells within different cancerous growths, called the “cell of origin”
SC rejects Bayer's appeal against compulsory licence for Nexavar
Indian pharma company, NATCO, can continue manufacturing generic version of liver and kidney cancer drug
Drug pricing body puts cap on trade margin for 42 anti-cancer drugs
Experts say move will not benefit patients as drug prices are already too high and the cap only negligible
Novartis loses patent appeal in landmark suit
Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …